the first to identify the role that the innate immunity receptor CD36 plays in damaging cerebral blood vessels and promoting the accumulation of amyloid deposits in these vessels, a condition known as cerebral amyloid angiopathy (CAA). Practical Neurology asked one of the study authors, Costantino Iadecola, MD, a Professor of Neurology at Weill Cornell Medical College and director of the new Brain and Mind Research Institute at Weill Cornell Medical College, to discuss the findings.